Dynamic Medical Technologies Inc.

As of June 30, 2026, Dynamic Medical Technologies Inc. carries a market capitalization of 2.04B, placing it among publicly traded companies globally. Its enterprise value stands at 1.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Dynamic Medical Technologies Inc. has 39.93M shares outstanding.

As of June 30, 2026, Dynamic Medical Technologies Inc. trades at a trailing price-to-earnings ratio of 13.96. The price-to-sales ratio is 1.46, and the price-to-book ratio stands at 1.29.

As of June 30, 2026, Dynamic Medical Technologies Inc. trades at an EV/EBITDA multiple of 4.54 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 8.31 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Dynamic Medical Technologies Inc. trades at an EV/FCF ratio of 5.06, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.43B versus a market cap of 2.04B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Dynamic Medical Technologies Inc. maintains a current ratio of 2.17, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.42, indicating elevated leverage, while an interest coverage ratio of 68.01 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Dynamic Medical Technologies Inc. posted a return on equity (ROE) of 9.57, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.63 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.02, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.88, useful for judging operating efficiency across full business cycles. The company generates approximately 4.00M in revenue per employee across its workforce of 349.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.14 indicates how many times Dynamic Medical Technologies Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Dynamic Medical Technologies Inc. recorded 36.16M in income tax expense. That works out to an effective tax rate of 17.45, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 207.21M, leaving 146.07M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Dynamic Medical Technologies Inc.'s stock has declined approximately 20.35% over the past 52 weeks. The 50-day moving average sits at 53.17, while the 200-day moving average is 55.59.

Over the twelve months ended June 30, 2026, Dynamic Medical Technologies Inc. generated 1.40B in revenue and converted that into 146.07M in net income, yielding earnings per share of 4.27. EBITDA reached 315.85M, while operating income came in at 171.84M.

As of June 30, 2026, Dynamic Medical Technologies Inc. holds 1.19B in cash and equivalents against 382.73M in total debt, resulting in a net debt position of -595.56M. Total book value stands at 1.58B, with working capital of 996.05M providing operational flexibility.

Dynamic Medical Technologies Inc. produced 324.55M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -45.43M in capital expenditures, free cash flow totaled 279.11M - equivalent to 6.98 per share.

Over the twelve months ended June 30, 2026, Dynamic Medical Technologies Inc. posted a gross margin of 43.42, reflecting its pricing power and cost economics. The operating margin of 12.31 and net profit margin of 10.47 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Dynamic Medical Technologies Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 13.67, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 14.15, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Dynamic Medical Technologies Inc. shareholders.

Dynamic Medical Technologies Inc.'s most recent stock split took place on September 1, 2025 with a 10:11 split ratio.

As of June 30, 2026, Dynamic Medical Technologies Inc. has an Altman Z-Score of 2.19, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.